buthionine sulfoximine glutathione The synthesis inhibitor synergistically enhanced melphalan activity against preclinical models of multiple myeloma resistant human breast cancer cells Frontiers | Systemic L-Buthionine -S-R-Sulfoximine
Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum L Buthionine sulfoximine L Buthionine sulfoximine buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S Transferase Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () Preclinical evaluation of azathioprine plus
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



